Insulet Corp

PODD: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|z#LOCK|@<j&LOCK|R&>!lWL<

Insulet Earnings: Another Quarter of Stellar Demand for Omnipod 5 Insulin Pumps

Insulet delivered third-quarter revenue growth of 25% in constant currency and pushed up gross margin by 150 basis points after a savvy decision to consolidate all pumps to the Omnipod 5 platform.

Sponsor Center